178 related articles for article (PubMed ID: 34537422)
1. Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes.
Farhadfar N; Leather HL; Wang S; Burton N; IrizarryGatell V; Itzler R; Salloum RG; Wingard JR
Transplant Cell Ther; 2021 Dec; 27(12):1007.e1-1007.e8. PubMed ID: 34537422
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes and Healthcare Resource Utilization for Gastrointestinal Acute Graft-versus-Host Disease after Allogeneic Transplantation for Hematologic Malignancy: A Retrospective US Administrative Claims Database Analysis.
Johnson BH; Taylor A; Kim G; Drahos J; Yang J; Akbari M; Shah NN
Biol Blood Marrow Transplant; 2019 Apr; 25(4):834-841. PubMed ID: 30625389
[TBL] [Abstract][Full Text] [Related]
3. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation.
Yu J; Parasuraman S; Shah A; Weisdorf D
Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314
[TBL] [Abstract][Full Text] [Related]
4. Inpatient Healthcare Resource Utilization, Costs, and Mortality in Adult Patients with Acute Graft-versus-Host Disease, Including Steroid-Refractory or High-Risk Disease, following Allogeneic Hematopoietic Cell Transplantation.
Yu J; Judy JT; Parasuraman S; Sinha M; Weisdorf D
Biol Blood Marrow Transplant; 2020 Mar; 26(3):600-605. PubMed ID: 31678539
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
Yu J; Lal L; Anderson A; DuCharme M; Parasuraman S; Weisdorf D
Support Care Cancer; 2020 Nov; 28(11):5491-5499. PubMed ID: 32172407
[TBL] [Abstract][Full Text] [Related]
6. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Outcomes of Bacterial Bloodstream Infections during Acute Graft-versus-Host Disease Involving the Gastrointestinal Tract after Hematopoietic Cell Transplantation.
Petersen J; Lindner C; Hakki M
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1648-1653. PubMed ID: 31002988
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of acute steroid-refractory graft-versus-host disease in commercially insured pediatric patients.
Grabner M; Strati E; Sandman K; Forsythe A
J Manag Care Spec Pharm; 2021 May; 27(5):607-614. PubMed ID: 33908282
[No Abstract] [Full Text] [Related]
9. Clinical and Economic Burden of Multiple Double-Stranded DNA Viral Infections after Allogeneic Hematopoietic Cell Transplantation.
Hill JA; Moon SH; Chandak A; Zhang Z; Boeckh M; Maziarz RT
Transplant Cell Ther; 2022 Sep; 28(9):619.e1-619.e8. PubMed ID: 35764288
[TBL] [Abstract][Full Text] [Related]
10. Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation.
Fang J; Su Y; Zavras PD; Raval AD; Tang Y; Perales MA; Giralt S; Stern A; Papanicolaou GA
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1937-1947. PubMed ID: 32640313
[TBL] [Abstract][Full Text] [Related]
11. Healthcare Resource Utilization and Costs of Steroid-Associated Complications in Patients With Graft-Versus-Host Disease.
Bell EJ; Yu J; Bhatt V; Bunner SH; Lal LS; Galvin J; Weisdorf D
Transplant Cell Ther; 2022 Oct; 28(10):707.e1-707.e7. PubMed ID: 35483620
[TBL] [Abstract][Full Text] [Related]
12. Increased Health Care Utilization and Costs during Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndromes in Adolescents and Young Adults Compared with Children: A Multicenter Study.
Rangarajan HG; Smith LC; Stanek JR; Hall M; Abu-Arja R; Auletta JJ; O'Brien SH
Biol Blood Marrow Transplant; 2019 May; 25(5):1031-1038. PubMed ID: 30625391
[TBL] [Abstract][Full Text] [Related]
13. Healthcare utilization and financial impact of acute-graft-versus host disease among children undergoing allogeneic hematopoietic cell transplantation.
Ricci A; Jin Z; Broglie L; Bhatia M; George D; Garvin JH; Hall M; Satwani P
Bone Marrow Transplant; 2020 Feb; 55(2):384-392. PubMed ID: 31537901
[TBL] [Abstract][Full Text] [Related]
14. Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Gjærde LK; Sørensen ALT; von Stemann JH; Fischer-Nielsen A; Hansen MB; Sengeløv H; Ostrowski SR
Transplant Cell Ther; 2021 Oct; 27(10):866.e1-866.e9. PubMed ID: 34252580
[TBL] [Abstract][Full Text] [Related]
15. Association between histopathological alterations and diarrhea severity in acute intestinal graft-versus-host disease.
da Costa LNG; Costa-Lima C; de Meirelles LR; Carvalho RB; Colella MP; Aranha FJP; Vigorito AC; De Paula EV
Medicine (Baltimore); 2018 May; 97(19):e0600. PubMed ID: 29742694
[TBL] [Abstract][Full Text] [Related]
16. Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants.
Watson C; Xu H; Princic N; Sruti I; Barlev A
J Med Econ; 2020 Oct; 23(10):1159-1167. PubMed ID: 32643493
[TBL] [Abstract][Full Text] [Related]
17. Late Effects of Severe Acute Graft-versus-Host Disease on Quality of Life, Medical Comorbidities, and Survival.
Rashid N; Krakow EF; Yeh AC; Oshima MU; Onstad L; Connelly-Smith L; Vo P; Mielcarek M; Lee SJ
Transplant Cell Ther; 2022 Dec; 28(12):844.e1-844.e8. PubMed ID: 36057421
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
Rezvani AR; Storer BE; Storb RF; Mielcarek M; Maloney DG; Sandmaier BM; Martin PJ; McDonald GB
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1594-601. PubMed ID: 21806949
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France.
Michonneau D; Quignot N; Jiang H; Reichenbach D; Kelly M; Burrell A; Zhang X; Thiruvillakkat K; Mohty M
Bone Marrow Transplant; 2023 May; 58(5):514-525. PubMed ID: 36765178
[TBL] [Abstract][Full Text] [Related]
20. Multi-parametric MRI in the diagnosis and scoring of gastrointestinal acute graft-versus-host disease.
Maccioni F; La Rocca U; Milanese A; Busato L; Cleri A; Lopez M; Manganaro L; De Felice C; Di Gioia C; Vestri AR; Catalano C; Iori AP
Eur Radiol; 2023 Sep; 33(9):5911-5923. PubMed ID: 37071163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
